Promiz Capsules (20mg & 40mg) – Advanced Omeprazole Proton Pump Inhibitor Therapy

Product Overview

Promiz Capsules are a high-potency, delayed-release Proton Pump Inhibitor (PPI) formulation containing Omeprazole. Specially engineered for the management of acid-related gastrointestinal conditions, Promiz provides long-lasting, 24-hour suppression of gastric acid production. Available in 20mg and 40mg strengths, Promiz effectively promotes the healing of erosive esophagitis, relieves Gastroesophageal Reflux Disease (GERD) symptoms, treats active gastric and duodenal ulcers, and forms a critical core of Helicobacter pylori eradication regimens.

Key Benefits

• Sustained 24-Hour Acid Relief: Delivers continuous, round-the-clock control of gastric acid output with convenient once-daily dosing.

• Accelerates Ulcer & Esophageal Healing: Rapidly reduces stomach acidity to allow active peptic ulcers and mucosal erosions in the esophagus to heal.

• Versatile Dosage Strengths: Offered in 20mg and 40mg strengths to support both maintenance therapy and intensive, acute clinical healing protocols.

• Key Component in H. pylori Eradication: Works synergistically with antibiotics to raise gastric pH and enhance bacterial eradication in peptic ulcer disease.

• Protects Against NSAID-Induced Lesions: Prevents and manages mucosal damage in patients requiring long-term nonsteroidal anti-inflammatory drug therapy.

How It Works

Promiz Capsules (Omeprazole) function as a selective and irreversible inhibitor of the H+/K+-ATPase enzyme system (the proton pump) located on the secretory surface of gastric parietal cells. As a lipophilic weak base, Omeprazole concentrates in the highly acidic environment of parietal cell canaliculi, where it is converted to its active sulfenamide form. This active compound forms a covalent disulfide bond with the cysteine residues of the H+/K+-ATPase enzyme, blocking the final step of gastric acid secretion and dramatically reducing both basal and stimulated acid output.

WooCommerce Attribute / Variation Details

Variation 1: PROMIZ CAPSULE 20MG

• SKU: PRO-CAP-20

• Short Description: Ideal for daily maintenance of healed erosive esophagitis, symptomatic GERD relief, and long-term NSAID-associated gastric ulcer prevention.

• Key Active Ingredient: Omeprazole (as delayed-release enteric-coated pellets) — 20mg per capsule.

• Target Indications: Mild-to-moderate GERD, maintenance of healed esophagitis, active duodenal ulcers, and prophylaxis against NSAID-induced gastric lesions.

• Standard Dosage: Administer 20mg once daily in the morning, 30 to 60 minutes before breakfast, or as directed by a healthcare professional.

Variation 2: PROMIZ CAPSULE 40MG

• SKU: PRO-CAP-40

• Short Description: High-strength formulation designed for intensive healing of severe erosive esophagitis, active gastric ulcers, and dual/triple H. pylori eradication regimens.

• Key Active Ingredient: Omeprazole (as delayed-release enteric-coated pellets) — 40mg per capsule.

• Target Indications: Severe erosive esophagitis, active benign gastric ulcers, H. pylori eradication protocols, and pathological hypersecretory conditions (such as Zollinger-Ellison syndrome).

• Standard Dosage: Administer 40mg once daily in the morning, 30 to 60 minutes before breakfast for 4 to 8 weeks, or as prescribed by a physician.

General Product Details (Shared across variations)

Key Active Ingredients

• Omeprazole (20mg / 40mg): Substituted benzimidazole proton pump inhibitor that suppresses gastric acid secretion by blocking parietal cell H+/K+-ATPase.

Directions for Use

1. Administration: Swallow the capsule whole with a glass of water. Do not chew, crush, or split the capsule, as the enteric-coated pellets protect the active drug from premature degradation in acidic stomach fluid.

2. Timing: Take once daily in the morning, at least 30 to 60 minutes before a meal for optimal activation and efficacy.

3. Duration: Continue therapy for the full course prescribed by your healthcare provider, even if symptoms improve quickly.

Precautions

• Prescription-only medication; use strictly under medical supervision.

• Response to Omeprazole therapy does not rule out underlying gastric malignancy; diagnostic evaluation is recommended if warning symptoms occur (e.g., unintended weight loss, recurrent vomiting, dysphagia, hematemesis).

• Prolonged use (exceeding 1 year) may increase the risk of hypomagnesemia, vitamin B12 deficiency, and osteoporotic bone fractures (hip, wrist, spine).

• May interact with drugs dependent on gastric pH for absorption (e.g., ketoconazole, iron salts) or metabolized by CYP2C19 (e.g., clopidogrel, diazepam).

• Consult a physician prior to use during pregnancy or lactation.

• Keep out of reach of children.

Storage Instructions

Store in a cool, dry place below 30°C, protected from direct sunlight, heat, and moisture. Keep capsules tightly closed in their original container or blister package.

Manufacturer Information

Formulated and manufactured in strict compliance with international pharmaceutical quality standards, dedicated to producing targeted gastroenterology solutions that restore mucosal integrity and support long-term digestive wellness.